News Chart GlycoNex Incorporation

Equities

4168

TW0004168000

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
28.2 ^TWD	+9.94%		+13.25%	-5.21%

05-28	Glyconex and Precisemab Sign Technology Licensing Agreement to Advance Development of Novel Anti-Glycan Antibodies for Cancer Therapy	CI
05-14	GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

336425ab0134d501e17b6f0659.mWS4VdFgeo_LGhU6ePzgz1sdhN9VQe-zvTrD-MqE2C8.1xP6eLtTJcmGXE15T5-s9h164bUiLbrk6GyPrKj8k0b4LO434isUu4xUUA~7b73823ec7d9076c973e850560e0fe72